THEOREM OPENS NEW STATE-OF-THE-ART CLINICAL SUPPLIES FACILITY

(King of Prussia, PA; May 14, 2015) — Theorem Clinical Research, a leading global contract research organization (CRO) that optimizes trial conduct, will open a new, state-of-the-art clinical supplies facility in Frankfurt, Germany, in June.

The current good manufacturing practice (cGMP)-compliant facility will triple Theorem's current clinical supplies capacity, with space for 2,700 square meters of ambient (15 to 25°C) and refrigerated (2 to 8°C) space. The opening also positions Theorem's clinical supplies hub near the Frankfurt Airport, a major transportation hub.

"We're excited to have the additional manufacturing and warehousing space and, more importantly, an infrastructure to deliver the flexibility our clients rely on," said John Potthoff, Theorem president and CEO. "The new facility will enhance speed and scalability while preserving the versatility of our supply solutions."

Theorem packages, labels, stores, distributes and reclaims pre-randomized study drugs and medical devices for studies worldwide. Theorem also provides qualified person services, as well as a range of temperature-controlled transport and logistics solutions, to facilitate the supply of global clinical trials. The launch of the new facility will strengthen current practices — such as its 24/7/365 storage, continuous monitoring and backup — and provides space for future service expansion.

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.